Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

osteoporosis/utrujenost

Povezava se shrani v odložišče
Stran 1 iz 17 rezultatov

Treating alzheimer's disease and osteoporosis and reducing aging

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND Alzheimer's disease is an age-related neurological disease characterized by memory loss and dementia. Osteoporosis, also an age-related disease, results in low bone mass and loss of bone tissue. There is a need to develop a new approach to treat these two age-related diseases or otherwise

Selective androgen receptor modulators

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity, which are nonsteroidal ligands for the androgen receptor. The agents are useful for a) male contraception; b) treatment of a variety of hormone-related

Selective androgen receptor modulators

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity, which are nonsteroidal ligands for the androgen receptor. The agents are useful for a) male contraception; b) treatment of a variety of hormone-related

Formulations comprising selective androgen receptor modulators

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to pharmaceutical compositions and formulations comprising a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new

Multi-substituted selective androgen receptor modulators and methods of use thereof

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor modulators

Multi-substitued selective androgen receptor modulators and methods of use thereof

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor

Methylene-bridged selective androgen receptor modulators and methods of use thereof

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which are selective androgen receptor modulators (SARM). The SARM compounds are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example

Heterocyclic selective androgen receptor modulators and methods of use thereof

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which are selective androgen receptor modulators (SARM). The SARM compounds are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example

Halogenated selective androgen receptor modulators and methods of use thereof

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor

Selective androgen receptor modulators and methods of use thereof

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor

N-bridged selective androgen receptor modulators and methods of use thereof

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor

Synthesis of selective androgen receptor modulators

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to a synthetic process for the preparation of a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of

Synthesis of selective androgen receptor modulators

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF INVENTION The present invention relates to a synthetic process for the preparation of a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of
The present invention relates to the use of one or more compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for the preparation of a therapeutical composition, in particular in the form of a food supplement, for the treatment of subjects suffering from
TECHNICAL FIELD The present application relates to the use of one or more compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for the preparation of a therapeutical composition, in particular, in the form of a food supplement, for the treatment of
Pridružite se naši
facebook strani

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

  • Deluje v 55 jezikih
  • Zeliščna zdravila, podprta z znanostjo
  • Prepoznavanje zelišč po sliki
  • Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
  • Preberite znanstvene publikacije, povezane z vašim iskanjem
  • Iščite zdravilna zelišča po njihovih učinkih
  • Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah

Google Play badgeApp Store badge